Macular Disease Foundation Australia logo

    MDFA News

    New Nutrition Guidelines for AMD

    Latest research supports Mediterranean and Asian-style eating plans to reduce risk of AMD

    Read more
    Back

    Most recent

    New stem cell models for dry AMD

    A years-long collaboration between some of Australia’s leading experts in stem cell biology, ophthalmology, and computational biology has produced a genetic roadmap for age-related macular degeneration (AMD) that could be a gamechanger for the discovery of novel treatments.

    Vabysmo® (faricimab) now available in Australia 

    Vabysmo is a new treatment for age-related macular degeneration and diabetic macular oedema and is now available on the Pharmaceutical Benefits Scheme (PBS) in Australia

    Welcome Dr. Kathy Chapman

    MDFA welcomed Dr Kathy Chapman as CEO in July

    Digital Diagnosis and Artificial Intelligence: Seeking Your Views  

    Attend any medical congress and you’ll increasingly hear the terms “artificial intelligence” and “digital diagnosis”

    Ophthalmologists needed for IVI digital support program

    Ophthalmologists needed for IVI digital support program

    Targeted patient content through MyInteract

    MDFA is partnering with MyInteract to provide targeted digital information and resources directly to people receiving intravitreal injections (IVI).

    World Sight Day at NSW Parliament

    Free vision screenings at NSW Parliament House on World Sight Day.

    Access and Affordability: Where Next?

    MDFA’s successful advocacy leading to the new Government’s rejection of the proposal to cut the MBS rebate for intravitreal injections leaves us with the question: what next?

    Loading...
    Loading...